St. George's Hospital NHS Trust
Paolo G. Casali
VCU Massey Cancer Center
ELCC News: Validation of the prognostic role of tumour lymphocytic infiltration on overall survival in patients with resectable NSCLC
LACE-Bio team confirms intense lymphocytic infiltration as a favourable prognostic factor
ELCC News: Biomarker analysis of the TORCH study shows that patients with advanced NSCLC should receive first-line erlotinib only if their tumour harbours EGFR mutations
Patients with unknown or negative EGFR mutation status should be treated with the standard chemotherapy first
ELCC News: A new genetic signature helps identify risk of relapse in patients with completely resected early NSCLC
The majority of the genes in the classifier are either immune-derived or immunomodulatory
ELCC News: A new potential biomarker of response in lung cancer chemoprevention studies
miR-34c is a transcriptional target of p53 and potentially new quantitative biomarker of response
Cancer Cell Line Encyclopedia may help to improve rare cancer research
First volume of the Cancer Cell Line Encyclopaedia catalogues the world’s cancer cell lines